Centaurea albonitens
Centaurea albonitens · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Centaurea albonitens is a distinctive botanical species that has garnered increasing interest within the field of pharmacological research. Scientific investigations often focus on its chemical complexity, particularly when utilizing a methanolic extract to isolate its bioactive components. This specific preparation method allows for the efficient extraction of diverse secondary metabolites present within the plant tissues. By analyzing these extracts, researchers aim to uncover the therapeutic potential and underlying medicinal properties of the species. Understanding the composition of this plant remains a vital step in exploring its contributions to natural product chemistry.
- Synonyms
- Phaeopappus Carthamoides · Tomanthea Carthamoides · 1 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Centaurea albonitens is a plant species that has been identified under several different botanical names throughout history. In various taxonomic records, it is recognized by the synonym Amberboa carthamoides. It is also frequently referred to in scientific literature as Phaeopappus carthamoides. Furthermore, the name Tomanthea carthamoides serves as another valid synonym for this specific taxon. Understanding these multiple nomenclatural connections is essential for accurate botanical identification and research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Centaurea albonitens is a specialized member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. The plant belongs to the order Asterales, showcasing its evolutionary connections to other flowering species. Further narrowing its lineage, it is categorized under the family Asteraceae. Finally, it is identified by its specific genus, Centaurea.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Centaurea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Centaurea albonitens is a distinctive plant species primarily found within the Asia-Temperate region. Its geographic range is specifically concentrated across parts of Western Asia, highlighting its unique ecological niche. Within this territory, the species maintains a notable presence in the country of Iran. Furthermore, it is widely distributed throughout the landscape of Türkiye. These specific locations define the natural habitat where this plant can be observed growing in the wild.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Conditions
Centaurea albonitens demonstrates significant potential as an anticancer agent through its ability to treat various leukemic cells. The methanolic extract of this plant effectively targets specific cell lines, including KMM-1 and NB4. Furthermore, the extract has shown cytotoxic effects against NALM-6 and REH cell lines by inducing apoptosis. These interactions suggest that the plant can play a vital role in combating different types of hematologic malignant cells. Overall, the research confirms that Centaurea albonitens exerts a therapeutic impact on these diverse leukemic models.
Preparations
Centaurea albonitens is prepared as a methanolic extract to investigate its potential therapeutic applications. This specific preparation, referred to as Centaurea albonitens extract (CAE), is evaluated for its cytotoxic effects against various leukemic cell lines. Researchers utilized this methanolic extract to determine its ability to induce apoptosis and G0/G1 phase arrest. The study specifically focuses on how this prepared extract can act alone or in combination with Vincristine to enhance anticancer activity. Ultimately, the methanolic extract of Centaurea albonitens serves as a key component in exploring new strategies for increasing chemotherapeutic sensitivity.